Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.
See Yourself at Telix
The Program Lead will be responsible for the successful development of Telix prostate cancer imaging products (up to and including Phase 3 clinical trials). The role will be responsible for creating, implementing, managing and executing the drug development plan. The successful delivery of the development plan will require leading a cross-functional team including manufacturing, non-clinical, clinical, quality and regulatory and a strong understanding of oncology drug development.
This role is critical to the further development and successful delivery of Telix’s product portfolio by driving the current and future development of this newly acquired product.
Key Accountabilities:
internally and externally.
Education and Experience:
Key Capabilities:
At Telix, we believe everyone counts, we strive to be extraordinary, and we pursue our goals with determination and integrity. You will be part of an engaged and supportive group of colleagues who all have a shared purpose: to help people with cancer and rare diseases live longer, better quality lives. Being a Telix employee means being a part of a unique, global, interdisciplinary team working to deliver what's next in precision medicine. We have hybrid and remote employees located all around the world. We offer competitive salaries, annual performance-based bonuses, an equity-based incentive program, generous vacation, paid wellness days and support for learning and development.
Telix Pharmaceuticals is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status, and other legally protected characteristics.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
At Telix Pharmaceuticals, we’re on a mission to redefine the future of cancer care, and we’re looking for a Global Product Development Lead – TLX599Px – Prostate Cancer Imaging to join our innovative team in the United States. As a rapidly advancing radiopharmaceutical company, we are dedicated to improving the quality of life for people living with cancer. In this exciting role, you will oversee the international rollout of our prostate cancer imaging agent and support the advancement of our late clinical-stage products. You’ll be responsible for implementing and executing a comprehensive drug development plan that requires strong leadership skills. You’ll collaborate with cross-functional teams encompassing manufacturing, non-clinical, clinical, quality, and regulatory functions, guiding our projects successfully through to the end of Phase 3 clinical trials. Your role will involve tracking project milestones, managing budgets, and maintaining transparent communication with stakeholders. We are looking for someone with a robust background in drug development who can thrive in a dynamic environment, adapt to changing priorities, and help us meet our corporate objectives. Join Telix and be part of a passionate team, all committed to making a meaningful impact in the lives of patients fighting cancer and rare diseases.
Telix Pharmaceuticals, established in 2018 and headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the Uni...
10 jobsSubscribe to Rise newsletter